FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093659845> ?p ?o ?g. }

• W3093659845 endingPage "592" @default.
• W3093659845 startingPage "583" @default.
• W3093659845 abstract "<b><i>Background:</i></b> We aimed to identify plasma markers of unfavorable outcomes for patients with acute ischemic stroke (AIS) after recanalization by endovascular thrombectomy (EVT). <b><i>Methods:</i></b> From November 2017 to May 2019, we prospectively collected 61 AIS patients due to anterior large vessel occlusion who achieved recanalization by EVT. Plasma samples were obtained between 18 and 24 h after recanalization. Unfavorable outcomes included futile recanalization at 90 days and overall early complications within 7 days after EVT. <b><i>Results:</i></b> After adjustment for age and initial National Institute of Health Stroke Scale (NIHSS), matrix metalloproteinase-9 (MMP-9), tenascin-C, thioredoxin, ADAMTS13, and gelsolin were independently associated with both futile recanalization and overall early complications significantly (all <i>p</i> &#x3c; 0.05), while C-reactive protein (CRP) was independently associated with overall early complications (<i>p</i> = 0.031) but at the limit of significance for futile recanalization (<i>p</i> = 0.051). The baseline clinical model (BCM) (including age and initial NIHSS) demonstrated discriminating ability to indicate futile recanalization (area under the curve [AUC] 0.807, 95% confidence interval [CI] 0.693–0.921) and overall early complications (AUC 0.749, 95% CI 0.611–0.887). BCM+MMP-9+thioredoxin enhanced discrimination (AUC 0.908, 95% CI 0.839–0.978, <i>p</i> = 0.043) and reclassification (net reclassification improvement [NRI] 67.2%, <i>p</i> &#x3c; 0.001) to indicate futile recanalization. With respect to overall early complications, BCM+MMP-9+tenascin-C, BCM+MMP-9+CRP, BCM+MMP-9+ADAMTS13, BCM+tenascin-C+ADAMTS13, and BCM+CRP+ADAMTS13, all improved discrimination (AUC [95% CI]: 0.868 [0.766–0.970], 0.882 [0.773–0.990], 0.886 [0.788–0.984], 0.880 [0.783–0.977], and 0.863 [0.764–0.962], respectively, all <i>p</i> &#x3c; 0.05 by the DeLong method) and reclassification (NRI 59.1%, 71.8%, 51.1%, 67.4%, and 38.3%, respectively, all <i>p</i> &#x3c; 0.05). <b><i>Conclusions:</i></b> The increased levels of MMP-9, tenascin-C, CRP, thioredoxin, and decreased levels of ADAMTS13 and gelsolin were independent predictors of futile recanalization in AIS patients after recanalization by EVT." @default.
• W3093659845 created "2020-10-29" @default.
• W3093659845 creator A5005367680 @default.
• W3093659845 creator A5006637294 @default.
• W3093659845 creator A5012783707 @default.
• W3093659845 creator A5016806891 @default.
• W3093659845 creator A5045608451 @default.
• W3093659845 creator A5056246750 @default.
• W3093659845 creator A5060118103 @default.
• W3093659845 creator A5080644954 @default.
• W3093659845 creator A5085470716 @default.
• W3093659845 creator A5088240763 @default.
• W3093659845 date "2020-01-01" @default.
• W3093659845 modified "2023-10-06" @default.
• W3093659845 title "Biomarkers of Unfavorable Outcome in Acute Ischemic Stroke Patients with Successful Recanalization by Endovascular Thrombectomy" @default.
• W3093659845 cites W1931044706 @default.
• W3093659845 cites W1965597112 @default.
• W3093659845 cites W1986058503 @default.
• W3093659845 cites W1995083451 @default.
• W3093659845 cites W2001313611 @default.
• W3093659845 cites W2002859772 @default.
• W3093659845 cites W2016420417 @default.
• W3093659845 cites W2031628998 @default.
• W3093659845 cites W2032547078 @default.
• W3093659845 cites W2056609724 @default.
• W3093659845 cites W2057039546 @default.
• W3093659845 cites W2067935721 @default.
• W3093659845 cites W2069521331 @default.
• W3093659845 cites W2091328561 @default.
• W3093659845 cites W2100001060 @default.
• W3093659845 cites W2100125187 @default.
• W3093659845 cites W2103114977 @default.
• W3093659845 cites W2154956836 @default.
• W3093659845 cites W2166015053 @default.
• W3093659845 cites W2171165037 @default.
• W3093659845 cites W2394495956 @default.
• W3093659845 cites W2526978419 @default.
• W3093659845 cites W2549017650 @default.
• W3093659845 cites W2563179587 @default.
• W3093659845 cites W2604363348 @default.
• W3093659845 cites W2606400921 @default.
• W3093659845 cites W2613621869 @default.
• W3093659845 cites W2748438376 @default.
• W3093659845 cites W2785667195 @default.
• W3093659845 cites W2792475126 @default.
• W3093659845 cites W2792516403 @default.
• W3093659845 cites W2802720163 @default.
• W3093659845 cites W2807713735 @default.
• W3093659845 cites W2893373748 @default.
• W3093659845 cites W2909634154 @default.
• W3093659845 cites W2915697325 @default.
• W3093659845 cites W2916242899 @default.
• W3093659845 cites W2916904588 @default.
• W3093659845 cites W2977469126 @default.
• W3093659845 doi "https://doi.org/10.1159/000510804" @default.
• W3093659845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33105129" @default.
• W3093659845 hasPublicationYear "2020" @default.
• W3093659845 type Work @default.
• W3093659845 sameAs 3093659845 @default.
• W3093659845 citedByCount "21" @default.
• W3093659845 countsByYear W30936598452021 @default.
• W3093659845 countsByYear W30936598452022 @default.
• W3093659845 countsByYear W30936598452023 @default.
• W3093659845 crossrefType "journal-article" @default.
• W3093659845 hasAuthorship W3093659845A5005367680 @default.
• W3093659845 hasAuthorship W3093659845A5006637294 @default.
• W3093659845 hasAuthorship W3093659845A5012783707 @default.
• W3093659845 hasAuthorship W3093659845A5016806891 @default.
• W3093659845 hasAuthorship W3093659845A5045608451 @default.
• W3093659845 hasAuthorship W3093659845A5056246750 @default.
• W3093659845 hasAuthorship W3093659845A5060118103 @default.
• W3093659845 hasAuthorship W3093659845A5080644954 @default.
• W3093659845 hasAuthorship W3093659845A5085470716 @default.
• W3093659845 hasAuthorship W3093659845A5088240763 @default.
• W3093659845 hasBestOaLocation W30936598451 @default.
• W3093659845 hasConcept C126322002 @default.
• W3093659845 hasConcept C127413603 @default.
• W3093659845 hasConcept C164705383 @default.
• W3093659845 hasConcept C2776268601 @default.
• W3093659845 hasConcept C2780645631 @default.
• W3093659845 hasConcept C44249647 @default.
• W3093659845 hasConcept C71924100 @default.
• W3093659845 hasConcept C78519656 @default.
• W3093659845 hasConceptScore W3093659845C126322002 @default.
• W3093659845 hasConceptScore W3093659845C127413603 @default.
• W3093659845 hasConceptScore W3093659845C164705383 @default.
• W3093659845 hasConceptScore W3093659845C2776268601 @default.
• W3093659845 hasConceptScore W3093659845C2780645631 @default.
• W3093659845 hasConceptScore W3093659845C44249647 @default.
• W3093659845 hasConceptScore W3093659845C71924100 @default.
• W3093659845 hasConceptScore W3093659845C78519656 @default.
• W3093659845 hasIssue "6" @default.
• W3093659845 hasLocation W30936598451 @default.
• W3093659845 hasOpenAccess W3093659845 @default.
• W3093659845 hasPrimaryLocation W30936598451 @default.
• W3093659845 hasRelatedWork W2077760523 @default.
• W3093659845 hasRelatedWork W2362796790 @default.
• W3093659845 hasRelatedWork W2387330792 @default.

• next